Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

• Main Authors: John A. Bartlett, Heather J. Ribaudo, Carole L. Wallis, Evgenia Aga, David A. Katzenstein, Wendy S. Stevens, Michael R. Norton, Karin L. Klingman, Mina C. Hosseinipour, John A. Crump, Khuanchai Supparatpinyo, Sharlaa Badal-Faesen, Beatrice A. Kallungal, Nagalingeswaran Kumarasamy
• Format: Journal
• Published: 2018
• Subjects: Immunology and Microbiology; Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84863718841&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/51726
• Institution: Chiang Mai University

Objective: To evaluate virologic response rates of lopinavir/ritonavir (LPV/r) monotherapy as second-line antiretroviral treatment (ART) among adults in resource-limited settings (RLSs). Design: An open-label pilot study of LPV/r monotherapy in participants on first-line nonnucleoside reverse transc...